2025年1月14日 · Evolocumab (brand name Repatha) is a PCSK9 inhibitor used for hypercholesterolemia (high cholesterol) and cardiovascular risk reduction. Includes …

Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human …

3 天之前 · Repatha (evolocumab) is a PCSK9 inhibitor used to lower high cholesterol alongside dietary changes and to reduce the risk of major cardiovascular events in those with …

2017年3月17日 · Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by …

2025年2月1日 · It is also used to reduce the risk of death, heart attack, stroke, unstable angina (chest pain) requiring hospitalization, or certain types of heart surgery in patients with existing …

What is Repatha® (evolocumab)? To reduce the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, certain types of chest …

Repatha (evolocumab) is commonly used for the following conditions. To lower the risk of heart attack, stroke, and certain types of heart surgery in people with heart disease

Evolocumab injection is used to reduce the risk of a stroke or heart attack or the need for coronary artery bypass (CABG) surgery in people with cardiovascular disease.

Evolocumab is a human monoclonal IgG2 directed against human proprotein convertase subtilisin kexin type 9 (PCSK9). PCSK9 binds to the low-density lipoprotein receptor (LDLR) on the …

5 天之前 · Used for secondary prevention to reduce risk of major adverse cardiovascular events (cardiovascular death, MI, stroke, unstable angina requiring hospitalization, or coronary …